Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
159 hedge funds and large institutions have $525M invested in Natus Medical Inc in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 68 reducing their positions, and 34 closing their positions.
8% less funds holding
Funds holding: 172 → 159 (-13)
12% less call options, than puts
Call options by funds: $726K | Put options by funds: $827K
23% less capital invested
Capital invested by funds: $683M → $525M (-$158M)
32% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 68
35% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$14.4M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$6.39M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$5.08M |
| 4 |
Goldman Sachs
New York
|
+$3.38M |
| 5 |
Millennium Management
New York
|
+$3.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$10.9M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
-$10.5M |
| 3 |
Bank of New York Mellon
New York
|
-$4.69M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$4.04M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$3.6M |
NTUS Hedge Fund Activity: Q3 2020 in Review
159 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2020, worth a combined $525M — down 23% from $683M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of NTUS and 22 opened new positions — a net loss of 12 holders — while 68 trimmed existing stakes and 46 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $14.4M. The largest seller was Cramer Rosenthal McGlynn, exiting entirely with an estimated $10.9M sold.
- 159 institutional investors held Natus Medical Inc (NTUS) as of Q3 2020, down from 172 in Q2 2020.
- Funds reported $525M of Natus Medical Inc stock for Q3 2020, down 23% quarter-over-quarter.
- 22 funds opened new Natus Medical Inc positions in Q3 2020 and 34 closed out, a net change of -12 holders.
- The largest Natus Medical Inc buyer in Q3 2020 was Janus Henderson Group, an estimated $14.4M added.
- The largest Natus Medical Inc seller in Q3 2020 was Cramer Rosenthal McGlynn, an estimated $10.9M sold.
Based on aggregated 13F filings for Q3 2020.